Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus

OBJECTIVE: Osteoprotegerin (OPG) acts as an important regulatory molecule in atherosclerosis. Recent studies report that thiazolidinediones could affect OPG expression. We investigated the relationship between OPG and inflammatory cytokines and the effects of pioglitazone (a PPARγ (PPARG) agonist) v...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Park, Jong Suk, Cho, Min Ho, Nam, Ji Sun, Yoo, Jeong Seon, Ahn, Chul Woo, Cha, Bong Soo, Kim, Kyung Rae, Lee, Hyun Chul
Format: Artigo
Langue:Inglês
Publié: BioScientifica 2011
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3000683/
https://ncbi.nlm.nih.gov/pubmed/20961967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-10-0875
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires